Provided is an anti-cadherin antibody having strong antibody-dependent cytotoxicity. The anti-cadherin antibody recognizes cadherin domain 4 (EC4), cadherin domain (EC5), or a domain upstream from EC1, and has an antibody-dependent cytotoxicity of 30% or greater at an antibody concentration of 1 µg/mL.
